分子洞察力解锁多发性骨髓瘤和骨疾病管理治疗潜力
Tiziana Bruno1, Valeria Catena1, Giovanni Blandino2
1SAFU Laboratory, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Journal of experimental & clinical cancer research : CR
|December 19, 2024
概括
新的研究强调了Che-1和Hippo通道的TAZ因子在多发性骨髓瘤 (MM) 之间的联系. 这种交叉提供了潜在的新治疗点来对抗MM骨病变.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 多发性髓瘤 (MM) 是血细胞的癌症,导致骨损伤和骨折.
- -1 (RNA聚合酶结合因子-1/AATF) 和Hippo通路与MM细胞存活和骨破坏有关.
研究的目的:
- 突出对MM扩散和骨损伤发展的新分子见解.
- 为了强调Che-1与Hippo通路的TAZ因子之间的相互作用.
主要方法:
- 关于MM中Che-1和Hippo通路的最近发现的评论.
- 对MM病原和骨解病变背后的分子机制的审查.
主要成果:
- 已经确定了Che-1和Hippo通路的共同转录因子TAZ之间的交叉声.
- 这种相互作用为限制MM骨病变的发展提供了新的分子标.
结论:
- -1和TAZ的相互作用代表了管理MM骨病的新疗法.
- 针对这种途径可以减少MM相关的发病率和死亡率.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
